Efficacy News and Research

RSS

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

An estimated 70–80% of ventilated patients will experience ICU delirium, which causes patients to enter a confused state and can lead to long-term cognitive impairments and memory deficits. GlobalData, therefore, expects to see an increase in the administration of pharmacological treatments for ICU delirium as the COVID-19 outbreak continues.

22 May 2020

Scientists identify compounds in noxious weed that reduce virulence of Staphylococcus bacteria

Scientists have identified specific compounds from the Brazilian Peppertree -- a weedy, invasive shrub in Florida -- that reduce the virulence of antibiotic-resistant staph bacteria.

22 May 2020

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

As the world struggles to overcome the current COVID-19 pandemic with non-pharmacological interventions, in the absence of an effective drug or vaccine, existing immunomodulators are being repurposed. A new study published on the preprint server medRxiv* in May 2020 shows no clinical benefit to the use of one such drug, called interferon beta 1b (IFN beta1b).

22 May 2020

Santen’s VEKTIS study demonstrates efficacy and tolerability of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivis, over 12 months

Santen EMEA is delighted to announce that the results of VEKTIS, a twelve month study in pediatric vernal keratoconjunctivitis have been published in the American Journal of Ophthalmology.

From Santen Pharmaceutical Co., Ltd. 22 May 2020

Excessive blood clotting and stroke in COVID-19 patients

The coronavirus disease COVID-19 is causing excessive blood clotting and stroke in young and healthy people, a new study has found.

21 May 2020

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

21 May 2020

Analysis: Get ready for the vaccine — they’re never simple

If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.

21 May 2020

Lattice light-sheet microscopy could help in drug and vaccine development

From testing drugs to developing vaccines, the close study of the immune system is key to improving real-world health outcomes. T-cells are integral to this research, as these white blood cells help tailor the body's immune response to specific pathogens.

21 May 2020

New strategy promotes healthy lifestyle behaviors in obese, overweight women

When researchers asked prospective study participants who they would like to see in videos promoting healthy lifestyle behaviors, the answer was unequivocal: They wanted to see themselves - that is, other mothers living in low-income households who were overweight or obese.

21 May 2020

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

PrECOG, LLC is reporting clinical efficacy and biomarker analyses from its single-arm phase two study PrE0505 for the initial treatment of patients with malignant pleural mesothelioma.

20 May 2020

FDA approves IND application by Octapharma USA for severe COVID-19 patients

The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression.

20 May 2020

New technique reveals potentially treatable mutations in subset of prostate cancer patients

Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable mutations in their DNA damage-repair genes, according to research published in the May issue of The Journal of Nuclear Medicine.

20 May 2020

Florida Hospital implement the Babyleo TN500 IncuWarmer beds from Draeger

Florida Hospital today announced it’s the first in the United States to implement the Babyleo TN500 IncuWarmer beds from Draeger, Inc., a world leader in medical technology. With an estimated 15 million babies born preterm annually according to the World Health Organization, this technology is critically important for both babies and families. The beds are in use in Neonatal Intensive Care Units (NICU) at three hospitals across the health system in Central Florida.

From Drägerwerk AG & Co. KGaA 20 May 2020

Landmark review outlines guidelines for new technologies to facilitate equitable, ethical use of AI

A landmark review of the role of artificial intelligence (AI) in the future of global health published in The Lancet calls on the global health community to establish guidelines for the development and deployment of new technologies and to develop a human-centered research agenda to facilitate equitable and ethical use of AI.

20 May 2020

Efficacy News and Research

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

Scientists identify compounds in noxious weed that reduce virulence of Staphylococcus bacteria

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

Santen’s VEKTIS study demonstrates efficacy and tolerability of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivis, over 12 months

Excessive blood clotting and stroke in COVID-19 patients

Comprehensive review of clioquinol drug gives valuable insights

Analysis: Get ready for the vaccine — they’re never simple

Lattice light-sheet microscopy could help in drug and vaccine development

New strategy promotes healthy lifestyle behaviors in obese, overweight women

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

FDA approves IND application by Octapharma USA for severe COVID-19 patients

New technique reveals potentially treatable mutations in subset of prostate cancer patients

Florida Hospital implement the Babyleo TN500 IncuWarmer beds from Draeger

Landmark review outlines guidelines for new technologies to facilitate equitable, ethical use of AI

Prellis Externalized Human Immune System produces human antibodies against SARS-Cov2

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia

Modified clinical trial design to meet urgent community needs during COVID-19 pandemic

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

New technique produces pure therapeutic drugs without the associated side effects

A minimally invasive approach to managing pain without opioids

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News